ArticleCancers2024

Regorafenib Treatment for Recurrent Glioblastoma Beyond Bevacizumab-Based Therapy: A Large, Multicenter, Real-Life Study.

Salih Tünbekici et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.